Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

677
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
677
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

357
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
357

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Bempedoic acid in real-world clinical practice: baseline and 8-week data from the Italian prospective, non-interventional MILOS study].

Giornale italiano di cardiologia (2006)·2026
Same author

Comparative efficacy and safety of olezarsen versus volanesorsen for familial chylomicronemia syndrome: a matching-adjusted indirect comparison.

Journal of comparative effectiveness research·2026
Same author

[Fish Oil for the Heart? The Role of Omega-3 Fatty Acids in Cardiovascular Medicine].

MMW Fortschritte der Medizin·2026
Same author

ATM Deficiency Induces TGFβ-Mediated Stromal Programming in Pancreatic Cancer.

Cancer research·2026
Same author

Pancreatic exocrine insufficiency after esophageal and gastric surgery: the PEGAS study.

Scandinavian journal of gastroenterology·2026
Same author

Pancreatic acinar cell cystadenoma: single-center experiences and a systematic review.

Scandinavian journal of gastroenterology·2026

Related Experiment Video

Updated: Mar 9, 2026

The Isolation of Flowing Mesenteric Lymph in Mice to Quantify In Vivo Kinetics of Dietary Lipid Absorption and Chylomicron Secretion
06:14

The Isolation of Flowing Mesenteric Lymph in Mice to Quantify In Vivo Kinetics of Dietary Lipid Absorption and Chylomicron Secretion

Published on: November 30, 2022

3.4K

Diagnostic algorithm for familial chylomicronemia syndrome.

Erik Stroes1, Philippe Moulin2, Klaus G Parhofer3

  • 1Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands.

Atherosclerosis. Supplements
|December 22, 2016
PubMed
Summary

Familial chylomicronemia syndrome (FCS) is a rare genetic disorder causing severe hypertriglyceridemia. A new diagnostic algorithm aims to help clinicians identify and manage patients with suspected FCS more effectively.

Keywords:
ChylomicronsFamilial chylomicronemia syndromeHyperlipoproteinemiaLipoprotein lipase deficiencyPancreatitis

More Related Videos

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format
05:58

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format

Published on: August 20, 2018

11.5K
Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome
06:48

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome

Published on: March 23, 2022

2.8K

Related Experiment Videos

Last Updated: Mar 9, 2026

The Isolation of Flowing Mesenteric Lymph in Mice to Quantify In Vivo Kinetics of Dietary Lipid Absorption and Chylomicron Secretion
06:14

The Isolation of Flowing Mesenteric Lymph in Mice to Quantify In Vivo Kinetics of Dietary Lipid Absorption and Chylomicron Secretion

Published on: November 30, 2022

3.4K
Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format
05:58

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format

Published on: August 20, 2018

11.5K
Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome
06:48

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome

Published on: March 23, 2022

2.8K

Area of Science:

  • Genetics
  • Metabolic Disorders
  • Clinical Diagnostics

Background:

  • Familial chylomicronemia syndrome (FCS) is a rare genetic disorder characterized by severe hypertriglyceridemia and recurrent pancreatitis.
  • Diagnosis is challenging due to rarity and non-specific symptoms, requiring multidisciplinary expertise.
  • Lack of a consensus on diagnostic best practices hinders effective patient identification.

Purpose of the Study:

  • To establish a diagnostic algorithm for Familial chylomicronemia syndrome (FCS).
  • To provide guidance for practitioners in diagnosing suspected FCS cases.
  • To optimize therapeutic strategies for individuals with FCS.

Main Methods:

  • Convened a board of European experts in lipidology, endocrinology, gastroenterology, and pancreatology.
  • Merged multidisciplinary perspectives to develop a consensus diagnostic approach.
  • Formulated a diagnostic algorithm for FCS.

Main Results:

  • A novel diagnostic algorithm for Familial chylomicronemia syndrome (FCS) has been developed.
  • The algorithm integrates expert consensus for improved diagnostic accuracy.
  • This represents a significant step towards standardized FCS diagnosis.

Conclusions:

  • The proposed diagnostic algorithm can aid primary and secondary care practitioners.
  • It supports the recognition of clinical signs and manifestations of FCS.
  • Facilitates earlier and more accurate diagnosis of Familial chylomicronemia syndrome.